As a leading recombinant protein and antibody manufacturer, Sino Biological has the biggest validated recombinant protein bank (6000+) in the world covering existing drug targets, cytokines, and viral proteins.
Sino Biological is the first company that expressed SARS-CoV-2 antigens and so far still has the most complete COVID19-related product collection with high quality.
We've been cooperating with the most important COVID19 vaccine/therapy/diagnostic assay developers, producing every month at the industrial scale of different SARS-CoV-2 antigens and antibodies.
Based on its rich experience and expertise, Sino Biological also provides the customized services for recombinant production of proteins and antibodies, as well as for traditional antibody development, to our global biotech and biopharm customers. Sino Biological Europe GmbH sits in Frankfurt, Germany, with a local sales and service team, and with our protein inventory.